Citations

Clear

114 citation(s) found for "Maria, Lapid".

Clinical Phenomenology and Characteristics of Centenarians in Hospice
Schoonover, Kimberly , Schoonover, Kimberly L, Lapid, Maria I.

Mayo Clinic

Journal of Palliative Care | September 19, 2018 | Volume: 34 | Issue: 1 | Pages: 47-51

10.1177/0825859718800491 | PMID 30229699 Get It

Objectives: Little is known about the hospice experience of centenarians. As the population of centenarians is projected to increase, understanding their unique end-of-life needs will be important to inform delivery of quality end-of-life care. Our objective was to characterize the hospice experience of centenarians. Methods: A retrospective single-institution cohort study of centenarians enrolled in hospice from January 1, 2015, to December 31, 2017, was conducted to collect demographic and clinical information. Results: Seventeen centenarians, who comprised 1.4% of hospice admissions, had an average age of 102 years, were mostly female (71%) and widowed (76%), and all caucasian. Upon hospice admission, centenarians resided in nursing (8, 47%) and assisted living (4, 24%) residencies as well as at home (4, 24%) and in senior independent living (1, 6%). Sixty percent of centenarians died in a nursing home. The most common hospice admission diagnosis was dementia (35%). Median length of stay on hospice was 41 days (range: 16-85) for 15 persons who died or discharged live. Conclusions: In this group of centenarians, dementia was the most common condition for hospice enrollment. Slightly less than half resided in nursing homes on admission, although death occurred most frequently in a nursing home. Centenarians were generally able to remain out of the hospital at their time of death.
Evidence for telehealth group-based treatment: A systematic review
Gentry, Melanie T. , Clark, Matthew M. , Rummans, Teresa A. , Gentry, Melanie T , Lapid, Maria I.

Mayo Clinic

Journal of Telemedicine and Telecare | May 23, 2018 | Volume: 25 | Issue: 6 | Pages: 327-342

10.1177/1357633x18775855 | PMID 29788807 Get It

Background Interest in the use of telehealth interventions to increase access to healthcare services is growing. Group-based interventions have the potential to increase patient access to highly needed services. The aim of this study was to systematically review the available literature on group-based video teleconference services. Methods The English-language literature was searched using Ovid MEDLINE, PubMed, PsycINFO and CINAHL for terms related to telehealth, group therapy and support groups. Abstracts were reviewed for relevance based on inclusion criteria. Multiple study types were reviewed, including open-label, qualitative and randomised controlled trial study designs. Data were compiled regarding participants, study intervention and outcomes. Specific areas of interest were the feasibility of and satisfaction with telehealth technology, as well as the effect of video teleconference delivery on group dynamics, including therapeutic alliance. Results Forty published studies met the inclusion criteria and were included in the review. Six were randomised controlled trials. Among the studies, there was a broad range of study designs, participants, group interventions and outcome measures. Video teleconference groups were found to be feasible and resulted in similar treatment outcomes to in-person groups. However, few studies were designed to demonstrate noninferiority of video teleconference groups compared with in-person groups. Studies that examined group process factors showed small decreases in therapeutic alliance in the video teleconference participants. Conclusions Video teleconference groups are feasible and produce outcomes similar to in-person treatment, with high participant satisfaction despite technical challenges. Additional research is needed to identify optimal methods of video teleconference group delivery to maximise clinical benefit and treatment outcomes.
“Keep the faith”: Spirituality as a contributor to resiliency in five elderly people
Sytsma, Terin T. , Schmelkin, Leah A., Jenkins, Sarah M. , Lovejoy, Laura A., Piderman, Katherine M. , Lapid, Maria I.

Mayo Clinic

Journal of Religion, Spirituality & Aging | March 14, 2018 | Volume: 30 | Issue: 4 | Pages: 314-324

10.1080/15528030.2018.1441095 Get It

A Lack of Systemic Absorption Following the Repeated Application of Topical Quetiapine in Healthy Adults
Kayhart, Bryce M., Nelson, Sarah , Cunningham, Julie L. , Thompson, Virginia H., Leung, Jonathan G. , Kayhart, Bryce, Leung, Jonathan G , Lapid, Maria I.

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | January 19, 2018 | Volume: 35 | Issue: 8 | Pages: 1076-1080

10.1177/1049909117753828 | PMID 29343085 Get It

In the absence of suitable oral or intravenous access for medication administration and when the intramuscular medications are undesirable, alternative routes for drug delivery may be considered. Antipsychotics administered via an inhaled, intranasal, rectal, or topical route have been described in the literature. Topically administered antipsychotics have been previously reported to produce negligible systemic absorption despite being used in clinical practice for nausea and behavioral symptoms associated with dementia. Additionally, the American Academy of Hospice and Palliative Medicine recommends against the use of topical medications that lack supporting literature. Three studies have assessed the systemic absorption of different antipsychotics after administration of only a single, topically applied dose. To evaluate whether the repeated administration of a topically applied antipsychotic may result in detectable serum levels in an accumulating fashion, a pharmacokinetic study was conducted. Five healthy, adult participants consented to receive extemporaneously prepared topical quetiapine in Lipoderm every 4 hours for a total of 5 doses. Blood samples were drawn at baseline and hours 2, 4, 8, 12, 16, and 24, and serum quetiapine concentrations were measured using high-performance liquid chromatography. Quetiapine was undetectable in every sample from 3 participants. Two participants had minimally detectable serum quetiapine levels no sooner than hour 12 of the study period. Extemporaneously prepared quetiapine in Lipoderm resulted in nonexistent or minimal serum level following repeated topical administration. The use of topically applied quetiapine should still be questioned.
Addressing goals of care in the never-competent patient
Wu, Kelly L. , Reinemann, Jaclyn M., Lapid, Maria I.

Mayo Clinic

Journal of Intellectual & Developmental Disability | November 3, 2017 | Volume: 45 | Issue: 1 | Pages: 30-34

10.3109/13668250.2017.1384905 Get It

Use of Electroconvulsive Therapy in Dementia-Related Agitation
Burton, M. Caroline , Koeller, Sandra L., Brekke, Frank M., Afonya, Adonye T., Sutor, Bruce, Lapid, Maria I.

Mayo Clinic

The Journal of ECT | June 28, 2017 | Volume: 33 | Issue: 4 | Pages: 286-289

10.1097/yct.0000000000000432 | PMID 28658012 Get It

Objectives This naturalistic prospective observation study examines the efficacy of electroconvulsive therapy (ECT) in treating dementia-related agitation. Methods Patients with dementia-related agitation who received ECT were compared with patients with the same condition who did not receive ECT using Cohen-Mansfield Agitation Inventory (CMAI), Neuropsychiatric Inventory (NPI)—nursing home version, and Clinical Global Impression Scale (CGI). Outcomes were compared between ECT-treated and non–ECT-treated patients. Results A total of 9 patients were included in the study. Six received ECT, and 3 did not. Patients in the ECT and non–ECT-treated groups had comparable baseline scores (CMAI, P = 0.880; NPI, P = 0.814; and CGI, P = 0.445). The CMAI, NPI, and CGI scores were lower on final assessment in both groups with no statistically significant difference (CMAI, P = 0.771; NPI, P = 0.243; and CGI, P = 0.519). Conclusions Electroconvulsive therapy should be considered as a treatment option in the management of severe treatment refractory dementia-related agitation.
The impact of a spiritual legacy intervention in patients with brain cancers and other neurologic illnesses and their support persons
Piderman, Katherine M. , Breitkopf, Carmen Radecki , Jenkins, Sarah M. , Kwete, Gracia M., Sytsma, Terin T. , Lovejoy, Laura A., Yoder, Timothy J., Jatoi, Aminah , Radecki Breitkopf, Carmen, Lapid, Maria I.

Mayo Clinic

Psycho-Oncology | December 9, 2015 | Volume: 26 | Issue: 3 | Pages: 346-353

10.1002/pon.4031 | PMID 26643586 Get It

AbstractObjectiveThe objectives were to assess the feasibility of using a novel, comprehensive chaplain‐led spiritual life review interview to develop a personal Spiritual Legacy Document (SLD) for persons with brain tumors and other neurodegenerative diseases and to describe spiritual well‐being (SWB), spiritual coping, and quality of life (QOL) of patients and their support persons (SP) before and after receipt of the SLD.MethodsPatient‐SP pairs were enrolled over a 2‐year period. Assessments included the Functional Assessment of Chronic Illness Therapy‐Spiritual Expanded Version, Brief Religious Coping Scale, Brief COPE Inventory, and QOL Linear Analog Scale. Baseline assessments were completed prior to an audio‐recorded spiritual life review interview with a chaplain.ResultsThirty‐two patient/SP pairs were enrolled; 27 completed baseline assessments and the interview. Twenty‐four reviewed their SLD and were eligible for follow‐up. A total of 15 patients and 12 SPs completed the 1‐month follow‐up; 10 patients and seven SPs completed the 3‐month follow‐up. Patients endorsed high levels of SWB and spiritual coping at baseline. Both patients and SPs evidenced improvement on several aspects of SWB, spiritual coping, and QOL at 1 month, but patients' decreased financial well‐being was also observed. Patients and SPs demonstrated favorable changes in peacefulness and positive religious coping at both time points.ConclusionsA chaplain‐led spiritual life review is a feasible intervention for patients with neurodegenerative disease and results in beneficial effects on patients and SPs. Copyright © 2015 John Wiley & Sons, Ltd.
Cancer caregiver quality of life: need for targeted intervention
Atherton, Pamela J., Kung, Simon , Sloan, Jeff A. , Shahi, Varun, Clark, Matthew M. , Rummans, Teresa A. , Atherton, Philip J. , Lapid, Maria I. , Atherton, Pamela J., Atherton, Philip J.

Mayo Clinic

Psycho-Oncology | September 11, 2015 | Volume: 25 | Issue: 12 | Pages: 1400-1407

10.1002/pon.3960 | PMID 26360934 Get It

AbstractObjectivesCaregiving can negatively impact well‐being. Cancer caregivers face unique challenges given the intense nature of cancer and treatment, which increases their risk for burden, poor quality of life (QOL), and burnout. Studies to reduce caregiver burden demonstrate QOL improvement and distress reduction in the short term. However, few studies exist to address long‐term benefits. We assessed changes in various QOL domains after participation in a QOL intervention for caregivers of patients having newly diagnosed advanced cancer.MethodsOur institutional review board‐approved study randomized patient–caregiver dyads to either usual care or an in‐person group intervention composed of six 90‐min sessions of structured multidisciplinary QOL components delivered over 4 weeks, with 10 follow‐up phone calls within 20 weeks. Caregivers attended four of the six sessions attended by patients. Sessions included physical therapy, coping and communication strategies, mental health education, spirituality, and social needs. Caregiver QOL (Caregiver Quality of Life Index‐Cancer Scale [CQOLC] and Linear Analogue Self‐Assessment [LASA]) and mood (Profile of Mood States‐Brief [POMS‐B]) were measured at baseline and 4, 27, and 52 weeks. Wilcoxon tests and effect sizes were used to compare the caregiver groups.ResultsOf the 131 caregivers (65 intervention and 66 usual care), 116 completed the study. Caregivers post‐intervention (at 4 weeks) had improved scores on LASA Spiritual Well‐being; POMS‐B total score, Vigor/Activity, and Fatigue/Inertia; and CQOLC Adaptation. At long term (at 27 weeks), caregivers retained improvement in POMS‐B Fatigue/Inertia and gained improvements in CQOLC Disruptiveness and Financial Concerns.ConclusionsCaregivers who received the intervention had higher QOL ratings for specific QOL domains but not for overall QOL. Although a comprehensive intervention was helpful, more specific, targeted interventions tailored for individual needs are recommended. Copyright © 2015 John Wiley & Sons, Ltd.
Cancer Caregiver: Perceived Benefits of Technology
Atherton, Pamela J., Clark, Matthew M. , Kung, Simon , Sloan, Jeff A. , Rummans, Teresa A. , Lapid, Maria I. , Atherton, Pamela J.

Mayo Clinic

Telemedicine and e-Health | June 15, 2015 | Volume: 21 | Issue: 11 | Pages: 893-902

10.1089/tmj.2014.0117 | PMID 26075800 Get It

Background: The burden associated with caregiving has been well documented. Caregivers have multiple responsibilities, and technology may be accessible as a potential burden-alleviating resource. Materials and Methods: We surveyed cancer caregivers regarding current technology use and willingness to use technology for easing burden or distress. Because age has been associated with technology use, responses were compared between geriatric (≥65 years old) and nongeriatric (18–64 years old) caregivers. Results: We had 112 respondents. Based on nonmissing responses, 66% ( n =71) were women, 95% ( n =106) were white, and 84% ( n =91) had post–high school education. Almost all caregivers reported having Internet (105 [94%]) and e-mail (102 [91%]) access. Nongeriatric caregivers indicated more willingness to access Internet-based tools that help caregivers (54 [93%] versus 41 [76%]; p =0.04) and were more frequent users of social media (37 [64%] versus 16 [30%]; p =0.01), smartphones (33 [57%] versus 16 [30%]; p =0.01), and other mobile wireless devices (42 [72%] versus 19 [35%]; p <0.001) than geriatric caregivers. They also more frequently expected technologies to improve their own quality of life ( p =0.009), increase their feelings of being effective as a caregiver ( p =0.02), and save time ( p =0.003). Regardless of age, a majority of caregivers (67 [62%]) endorsed the potential benefit of caregiving technologies in preventing burnout. Conclusions: Most caregivers have high access to and use of technology. Geriatric and nongeriatric caregivers were receptive to technology-based tools to help with their caregiving roles. Although nongeriatric caregivers expected to derive more benefit from such tools, both groups believed that caregiving technologies could reduce burden.